Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
Use this SGMO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SGMO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SGMO SEC filings page. Lician reads the product cache first so this HTML stays unique to Sangamo Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SGMO income, balance, and cash tables.